FDA Drug recall D-0282-2022
Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc
- FDA Drug
- Class II
- terminated
- Published 2021-12-22
On 2021-12-22 the FDA classified a Class II recall of Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc by Tolmar, citing superpotent Drug.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0282-2022 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2021-11-08 |
| Published | 2021-12-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Tolmar |
| Distribution | US |
Product
Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc. Fort collins, CO 80526, NDC 0781-7263-68
Reason
Superpotent Drug
Identifiers
| code_info | Lot #: 11557C1, Exp. Date: Feb 2022; 11552B1, Exp. Date Apr 2022; 12206A1, Exp. Date: Nov 2022 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0282-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.